Nektar Therapeutics
NKTR
NKTR
132 hedge funds and large institutions have $168M invested in Nektar Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.8% more ownership
Funds ownership: 4.1% → 4.91% (+0.8%)
35% less call options, than puts
Call options by funds: $50K | Put options by funds: $77K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
132
Holding in Top 10
–
Calls
$50K
Puts
$77K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$11.5M | |
| 3 | +$9.34M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.66M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.85M |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$3.33M | |
| 3 | -$3.25M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.73M |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$1.93M |